Searched for
INDIA CONTRACT DRUG MANUFACTURERS
Indian electronics manufacturers forge more and more partnerships with companies from South Korea, Taiwan, JapanIndian electronics manufacturers are forging alliances with firms from South Korea, Taiwan and Japan, alongside exploring standalone initia...- East Wing Ballroom Executive Residence Contract worth $500 million awarded without competitive bids? Check responsible firm, Donald Trump's roleEast Wing Ballroom Executive Residence Contract: U.S. President Donald Trump was directly involved in negotiating some costs for the ballr...
- Manufacturing growth seen moderating in Q1 as West Asia crisis weighs on sentiment: FICCIIndia's manufacturing sector anticipates a slowdown in April-June FY27, influenced by West Asia tensions impacting business confidence. Des...
- BPCL to buy 40% stake in Shell, Tiki Tar venture to expand value-added bitumen businessBharat Petroleum Corporation Ltd. is acquiring a 40% stake in Tiki Tar and Shell India for Rs 85 crore, marking its significant entry into ...
- India's industrial output quickens to 5.1% in May from 4.9% in April as manufacturing, electricity drive growthIndia's industrial production surged by 5.1% in May 2026, largely propelled by strong manufacturing activity despite a decrease in mining o...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...
- Karnataka: Chief Minister Shivakumar warns gutkha industry of ban if substances are foundKarnataka Chief Minister D K Shivakumar has warned the pan masala and gutkha industry of an outright ban if any intoxicating substances are...
- Vice President Radhakrishnan urges collective action to build drug-free IndiaVice President C.P. Radhakrishnan has called for a nationwide, collaborative effort to combat substance abuse, emphasizing the crucial role...
- Karnataka CM Shivakumar warns of ban on pan masala, gutka containing narcotic substancesKarnataka Chief Minister D K Shivakumar has vowed to ban pan masala and gutka if found laced with intoxicating substances, warning manufact...
- Startup founder claims foreign client honoured contract after dropping project internally, compares it to India's "adjust kar lo" cultureStartup founder's X post highlighted an international client's commitment to a paused six-month contract, contrasting it with India's often...
- Punjab drug body finds critical lapses at Jackson Laboratories' manufacturing facility in AmritsarThe Punjab FDA has taken decisive action by revoking the manufacturing licence of Jackson Laboratories in Amritsar due to severe regulatory...
- WHO seeks details from India over oxytocin-linked deaths; licences of manufacturer cancelledThe World Health Organisation (WHO) has sought details from the Indian government after reports linked oxytocin injections made by Jackson ...
- Govt to amend NDPS Act to plug loopholes exploited by narco syndicates: Amit ShahUnion Home Minister Amit Shah announced plans to amend the NDPS Act to combat drug syndicates, emphasizing a strict approach against peddle...
- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...
- USFDA concludes inspection at Jubilant HollisterStier's Spokane plant with 8 observationsJubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washingt...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
Load More
